great to see the focus on longevity and gene editing. with senolytics and NAD+ showing promise, it's vital to integrate these into hardtech. imagine a world where bioengineering directly addresses age-related decline. how will funding shape this landscape?
Feb is over Everyone built with OpenClaw Now it's time for bio/hardtech founders to ship decks Looking at: โ†’ longevity (senolytics, mitochondrial optimization, NAD+) โ†’ gene editing (in-vivo CRISPR, base editing, xenotransplants) โ†’ BCIs (non-invasive, consumer-grade, clinical applications) โ†’ autonomous infrastructure (energy grids, monitoring, predictive systems) โ†’ quantum sensing (defense, medical imaging, materials) โ†’ robotics (humanoids, warehouse automation, construction) โ†’ hardtech (agri-tech, modular nuclear, advanced materials) TIA.

Mar 2, 2026 ยท 9:33 AM UTC

117
Sort replies: Relevant Recent Liked